[PHARMA] QoQ Annualized Quarter Result on 30-Jun-2021 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
20-Aug-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
30-Jun-2021 [#2]
Profit Trend
QoQ- -20.38%
YoY- 13.78%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 3,848,696 4,815,015 5,471,062 3,941,244 3,173,996 2,725,071 2,787,317 24.02%
PBT 149,756 277,075 202,649 107,536 126,096 35,793 65,732 73.22%
Tax -34,332 -104,870 -86,596 -34,104 -34,784 -9,524 -21,310 37.46%
NP 115,424 172,205 116,053 73,432 91,312 26,269 44,421 89.11%
-
NP to SH 110,936 172,150 115,566 73,680 92,544 27,489 45,093 82.33%
-
Tax Rate 22.93% 37.85% 42.73% 31.71% 27.59% 26.61% 32.42% -
Total Cost 3,733,272 4,642,810 5,355,009 3,867,812 3,082,684 2,698,802 2,742,896 22.83%
-
Net Worth 413,947 450,411 391,428 357,275 355,919 337,298 345,040 12.91%
Dividend
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Div 41,918 121,768 75,056 60,200 41,872 28,761 34,852 13.10%
Div Payout % 37.79% 70.73% 64.95% 81.71% 45.25% 104.63% 77.29% -
Equity
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Net Worth 413,947 450,411 391,428 357,275 355,919 337,298 345,040 12.91%
NOSH 1,309,126 1,309,126 1,309,126 261,991 261,705 261,705 261,705 192.77%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin 3.00% 3.58% 2.12% 1.86% 2.88% 0.96% 1.59% -
ROE 26.80% 38.22% 29.52% 20.62% 26.00% 8.15% 13.07% -
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
RPS 293.80 367.74 417.92 301.16 1,212.81 1,042.20 1,066.33 -57.69%
EPS 8.48 13.15 8.83 5.64 35.36 10.51 17.25 -37.73%
DPS 3.20 9.30 5.73 4.60 16.00 11.00 13.33 -61.40%
NAPS 0.316 0.344 0.299 0.273 1.36 1.29 1.32 -61.47%
Adjusted Per Share Value based on latest NOSH - 261,991
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
RPS 267.04 334.08 379.60 273.46 220.22 189.08 193.40 24.02%
EPS 7.70 11.94 8.02 5.11 6.42 1.91 3.13 82.33%
DPS 2.91 8.45 5.21 4.18 2.91 2.00 2.42 13.09%
NAPS 0.2872 0.3125 0.2716 0.2479 0.247 0.234 0.2394 12.91%
Price Multiplier on Financial Quarter End Date
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Date 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 -
Price 0.755 0.74 0.835 5.29 3.26 5.00 4.32 -
P/RPS 0.26 0.20 0.20 1.76 0.27 0.48 0.41 -26.20%
P/EPS 8.92 5.63 9.46 93.96 9.22 47.56 25.04 -49.77%
EY 11.22 17.77 10.57 1.06 10.85 2.10 3.99 99.35%
DY 4.24 12.57 6.87 0.87 4.91 2.20 3.09 23.50%
P/NAPS 2.39 2.15 2.79 19.38 2.40 3.88 3.27 -18.87%
Price Multiplier on Announcement Date
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Date 20/05/22 17/02/22 19/11/21 20/08/21 21/05/21 17/03/21 19/11/20 -
Price 0.72 0.76 0.845 0.925 4.03 3.49 5.72 -
P/RPS 0.25 0.21 0.20 0.31 0.33 0.33 0.54 -40.18%
P/EPS 8.50 5.78 9.57 16.43 11.40 33.20 33.16 -59.68%
EY 11.76 17.30 10.45 6.09 8.77 3.01 3.02 147.71%
DY 4.44 12.24 6.79 4.97 3.97 3.15 2.33 53.76%
P/NAPS 2.28 2.21 2.83 3.39 2.96 2.71 4.33 -34.81%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment